JW Therapeutics CEO says Beijing scrutiny not impacting pharma deals

Investing.com Gold reports: JW Therapeutics CEO says Beijing scrutiny not impacting pharma deals. Full body text was unavailable at ingest time, so this brief is based on headline context.